FDA advisers say Bausch & Lomb implantable lens safe, effective

(Reuters) – An implantable lens designed by Bausch & Lomb Inc to reduce vision distortion as well as allow patients to focus on near and distant objects was safe and effective, advisers to the U.S. health regulator said. The Ophthalmic Devices Panel of the Medical Devices Advisory Committee voted 10-to-none that the company’s Trulign Toric Accommodating Posterior Chamber Intraocular Lens was safe. The lens — designed to move inside the eye — allows patient to focus on near, intermediate and distant objects without using spectacles after cataract surgeries. …